Meeting Register Page

AS: The Sweet Smell of Success in Sweden
Only 55% of American patients with low-risk prostate cancer go on active surveillance, UCSF researchers reported recently.
Ten years ago, only 6% of of these men went on AS. In contrast, the rate is above 90% in Sweden, according to Ola Bratt, MD, a prominent Swedish urologist.

Dr, Bratt is a consultant urological surgeon at the Prostate Cancer Centre, Sahlgrenska University Hospital
Gothenburg, Sweden. He is Chairman of the National Prostate Cancer Guidelines Group in Sweden.

Oct 30, 2021 12:00 PM in Eastern Time (US and Canada)

Meeting logo
* Required information